4//SEC Filing
ZERBE ROBERT L MD 4
Accession 0001140361-24-024334
CIK 0000887359other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:06 PM ET
Size
11.1 KB
Accession
0001140361-24-024334
Insider Transaction Report
Form 4
Vericel CorpVCEL
ZERBE ROBERT L MD
Director
Transactions
- Exercise/Conversion
Restricted Stock Unit
2024-05-01+3,200→ 0 total→ Common Stock (3,200 underlying) - Award
Restricted Stock Unit
2024-05-01+3,200→ 3,200 total→ Common Stock (3,200 underlying) - Exercise/Conversion
Common Stock
2024-05-01+3,200→ 26,595 total - Award
Stock Option (Right to Buy)
2024-05-01+8,000→ 8,000 totalExercise: $47.08Exp: 2034-05-01→ Common Stock (8,000 underlying)
Footnotes (6)
- [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on May 3, 2023.
- [F2]Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
- [F3]These RSUs vest 100% on the earlier of May 3, 2024, or the date of the first Annual Meeting of Stockholders following May 3, 2023.
- [F4]No expiration date for this type of award.
- [F5]The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.
- [F6]These RSUs vest 100% on the earlier of May 1, 2025, or the date of the first Annual Meeting of Stockholders following May 1, 2024.
Documents
Issuer
Vericel Corp
CIK 0000887359
Entity typeother
Related Parties
1- filerCIK 0001220363
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:06 PM ET
- Size
- 11.1 KB